COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO
- Status
- ENROLLING_BY_INVITATION
- Phase
- EARLY_PHASE1
Clinical Trials Related to Tacrolimus
Related studies linked through entity extraction aliases.
Allo HSCT for High Risk Hemoglobinopathies
- Status
- RECRUITING
- Phase
- PHASE2
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
- Status
- RECRUITING
- Phase
- PHASE2
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus
- Status
- RECRUITING
- Phase
- PHASE4
Trial of Cell Based Therapy for DMD
- Status
- RECRUITING
- Phase
- PHASE1
ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis
- Status
- RECRUITING
- Phase
- PHASE2
Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)
- Status
- COMPLETED
- Phase
- PHASE1
Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.
- Status
- RECRUITING
- Phase
- PHASE4
Belatacept in Heart Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.
- Status
- RECRUITING
- Phase
- PHASE2
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
- Status
- RECRUITING
- Phase
- PHASE2
Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination
- Status
- UNKNOWN
- Phase
- N/A
Topical Tacrolimus for Breast Cancer-related Lymphedema
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE2/PHASE3
225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure
- Status
- RECRUITING
- Phase
- PHASE3
Botox Versus Tacrolimus in Psoriasis Vulgaris
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE2